Soligenix (SNGX) Revenue (2010 - 2024)
Soligenix's (SNGX) quarterly Revenue came in at $2342.0 in Q2 2024, down 98.87% YoY from $206929.0 in Q3 2023, and down 98.0% on a QoQ basis from $117029.0 in Q1 2024.
Soligenix (SNGX) Revenue (2010 - 2024) Analysis & Trends
Soligenix (SNGX) has 15 years of Revenue data on file, last reported at $2342.0 in Q2 2024.
- Quarterly Revenue fell 98.87% year-over-year to $2342.0 in Q2 2024, while the trailing twelve-month figure through Dec 2024 was $119371.0 (down 85.78% YoY) and the FY2024 annual result came in at $119371.0, down 85.78% from the prior year.
- Revenue retreated to $2342.0 in Q2 2024, from $117029.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $924552.0 in Q1 2020 to a low of $2342.0 in Q2 2024.
- A 5-year average of $304732.7 and a median of $221732.0 in 2021 frame the typical range for Revenue.
- Annual changes were most pronounced in 2023 — Revenue jumped 36.75% — and 2024, when it plunged 98.87%.
- Tracing SNGX's Revenue over 5 years: stood at $714629.0 in 2020, then tumbled by 61.43% to $275653.0 in 2021, then soared by 32.8% to $366068.0 in 2022, then sank by 33.12% to $244812.0 in 2023, then plunged by 99.04% to $2342.0 in 2024.
- The last three Revenue figures came in at $2342.0 (Q2 2024), $117029.0 (Q1 2024), and $244812.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Soligenix | 6.06 Mn | 6.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 2,342.00 |
| Mar 31, 2024 | 117,029.00 |
| Dec 31, 2023 | 244,812.00 |
| Sep 30, 2023 | 130,440.00 |
| Jun 30, 2023 | 206,929.00 |
| Mar 31, 2023 | 257,178.00 |
| Dec 31, 2022 | 366,068.00 |
| Sep 30, 2022 | 166,140.00 |
| Jun 30, 2022 | 228,640.00 |
| Mar 31, 2022 | 188,063.00 |
| Dec 31, 2021 | 275,653.00 |
| Sep 30, 2021 | 186,198.00 |
| Jun 30, 2021 | 214,824.00 |
| Mar 31, 2021 | 147,593.00 |
| Dec 31, 2020 | 714,629.00 |
| Sep 30, 2020 | 608,811.00 |
| Jun 30, 2020 | 505,288.00 |
| Mar 31, 2020 | 924,552.00 |
| Dec 31, 2019 | 1.98 Mn |
| Sep 30, 2019 | 946,982.00 |